Insider · CIK 0001709954
Jonathan Gillis
Files at MPLT (MapLight Therapeutics, Inc.). First filing Apr 17, 2026, latest Jul 20, 2026.
In brief
Jonathan Gillis files SEC Form 4 as CFO at MPLT (MapLight Therapeutics, Inc.). Since Apr 17, 2026, Jonathan Gillis has reported 0 open-market buys worth $0 and 3 open-market sells worth $3.6M, the latest filed on Jul 20, 2026.
A track record needs three past buys with six months of prices behind them; Jonathan Gillis has 0, so none is measured yet.
The newest scored trade: sold $1.4M of MPLT on Jul 15, 2026, filed Jul 20, 2026, scored 47 (moderate), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 3 sells worth $3.6M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MPLT: MapLight Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 47Moderate | MapLight Therapeutics, Inc. | $1.4M 36,979 shares | -20% | +191% from low-6% from high | |
| 45Moderate | MapLight Therapeutics, Inc. | $2.1M 69,835 shares | -28% | +139% from low-5% from high | |
| 40Moderate | MapLight Therapeutics, Inc. | $96k 3,590 shares | -1% | +110% from low-9% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 17, 2026 | MPLT MapLight Therapeutics, Inc. | 18,469 0.04% of outstanding | $687k | Jul 17, 2026 | $2.8M |
| Jul 15, 2026 | MPLT MapLight Therapeutics, Inc. | 36,979 0.09% of outstanding | $1.4M | Jul 15, 2026 | $2.2M |
| Apr 27, 2026 | MPLT MapLight Therapeutics, Inc. | 69,835 0.16% of outstanding | $2.1M | Apr 27, 2026 | $96k |
| Apr 15, 2026 | MPLT MapLight Therapeutics, Inc. | 4,000 0.01% of outstanding | $108k | Apr 15, 2026 | none |
Transactions
Every row this insider has filed, 22 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | MPLT MapLight Therapeutics, Inc. | AGrant or award Voting Common Stock | +6,020 | $0.00 | $0 | 150,260 | Aug 19, 2026 |
| Aug 17, 2026 | MPLT MapLight Therapeutics, Inc. | AGrant or award Voting Common Stock | +2,222 | $0.00 | $0 | 152,482 | Aug 19, 2026 |
| Aug 17, 2026 | MPLT MapLight Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +24,455 | $0.00 | $0 | 24,455 | Aug 19, 2026 |
| Aug 17, 2026 | MPLT MapLight Therapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +2,813 | $0.00 | $0 | 2,813 | Aug 19, 2026 |
| Jul 15, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -5,356 | $36.13 | $194k | 175,863 | Jul 20, 2026 |
| Jul 15, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -4,699 | $36.94 | $174k | 171,164 | Jul 20, 2026 |
| Jul 16, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -6,979 | $36.66 | $256k | 164,185 | Jul 20, 2026 |
| Jul 16, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -1,476 | $37.44 | $55k | 162,709 | Jul 20, 2026 |
| Jul 17, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -600 | $36.51 | $22k | 162,109 | Jul 20, 2026 |
| Jul 17, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -16,969 | $37.61 | $638k | 145,140 | Jul 20, 2026 |
| Jul 17, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -900 | $38.17 | $34k | 144,240 | Jul 20, 2026 |
| Apr 27, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -7,914 | $28.94 | $229k | 243,140 | Apr 29, 2026 |
| Apr 27, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -29,623 | $29.60 | $877k | 213,517 | Apr 29, 2026 |
| Apr 27, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -14,363 | $30.46 | $437k | 199,154 | Apr 29, 2026 |
| Apr 28, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -17,235 | $30.33 | $523k | 181,919 | Apr 29, 2026 |
| Apr 28, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock10b5-1 | -700 | $30.83 | $22k | 181,219 | Apr 29, 2026 |
| Apr 15, 2026 | MPLT MapLight Therapeutics, Inc. | SOpen-market sale Voting Common Stock | -3,590 | $26.61 | $96k | 251,054 | Apr 17, 2026 |
| Feb 5, 2026 | MPLT MapLight Therapeutics, Inc. | AGrant or award Voting Common Stock | +6,020 | $0.00 | $0 | 254,523 | Feb 9, 2026 |
| Feb 5, 2026 | MPLT MapLight Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +24,455 | $0.00 | $0 | 24,455 | Feb 9, 2026 |
| Jan 27, 2026 | MPLT MapLight Therapeutics, Inc. | FTax withholding Voting Common Stock | -22,050 | $17.98 | $396k | 248,503 | Jan 29, 2026 |
| Oct 27, 2025 | MPLT MapLight Therapeutics, Inc. | AGrant or award Voting Common Stock | +30,565 | $0.00 | $0 | 30,565 | Oct 28, 2025 |
| Oct 27, 2025 | MPLT MapLight Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +124,022 | $0.00 | $0 | 124,022 | Oct 28, 2025 |
Questions about Jonathan Gillis
Answered from the filings on this page, as of the latest one.
Is Jonathan Gillis buying or selling?
In the last 12 months Jonathan Gillis reported 0 open-market buys worth $0 and 3 open-market sells worth $3.6M on SEC Form 4; the latest was sold $1.4M of MPLT on Jul 15, 2026. Grants, option exercises and tax withholding are not counted.
How did Jonathan Gillis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan Gillis has 0.
Where does Jonathan Gillis file Form 4?
Jonathan Gillis has filed Form 4 at MPLT (MapLight Therapeutics, Inc.) as CAO and Interim CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.